WHO ICTRP trial
Safety evaluation of test products by PIPT
CTRI/2023/03/050887 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2023/03/050887 |
|---|---|
| Public title | Safety evaluation of test products by PIPT |
| Scientific title | Dermatological safety evaluation of test products by Primary Irritation Patch Test within 24 hours of apply on healthy human all skin types |
| Primary sponsor | Dabur India Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Interventions | Intervention1: Face Scrub: cosmetics Intervention2: Face cream: cosmetics Intervention3: Face cleanser: Cosmetics Control Intervention1: Negative Control: 0.9 % Normal Saline Control Intervention2: Positive Control (SLS): 1 % w/w in… |
| Registration date | Mar 20, 2023 |
| Target size | 24 |
| Secondary IDs | TG/CLI/069b Version 1.0 & Dated 04 Mar 2023 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: